These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 33399986)

  • 1. Receptor for Advanced Glycation End Products (RAGE) and Its Polymorphic Variants as Predictive Diagnostic and Prognostic Markers of NSCLCs: a Perspective.
    Mukherjee TK; Malik P; Hoidal JR
    Curr Oncol Rep; 2021 Jan; 23(1):12. PubMed ID: 33399986
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The receptor for advanced glycation end-products enhances lung epithelial wound repair: An in vitro study.
    Zhai R; Blondonnet R; Ebrahimi E; Belville C; Audard J; Gross C; Choltus H; Henrioux F; Constantin JM; Pereira B; Blanchon L; Sapin V; Jabaudon M
    Exp Cell Res; 2020 Jun; 391(2):112030. PubMed ID: 32330509
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical Implications of High-mobility Group Box-1 (HMGB1) and the Receptor for Advanced Glycation End-products (RAGE) in Cutaneous Malignancy: A Systematic Review.
    Nguyen AH; Detty SQ; Agrawal DK
    Anticancer Res; 2017 Jan; 37(1):1-7. PubMed ID: 28011467
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel polymorphism in the promoter of the RAGE gene is associated with non-small cell lung cancer.
    Schenk S; Schraml P; Bendik I; Ludwig CU
    Lung Cancer; 2001 Apr; 32(1):7-12. PubMed ID: 11282423
    [TBL] [Abstract][Full Text] [Related]  

  • 5. RAGE genetic polymorphisms are associated with risk, chemotherapy response and prognosis in patients with advanced NSCLC.
    Wang X; Cui E; Zeng H; Hua F; Wang B; Mao W; Feng X
    PLoS One; 2012; 7(10):e43734. PubMed ID: 23071492
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Implication of RAGE Polymorphic Variants in COPD Complication and Anti-COPD Therapeutic Potential of sRAGE.
    Malik P; Hoidal JR; Mukherjee TK
    COPD; 2021 Dec; 18(6):737-748. PubMed ID: 34615424
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The AGE-RAGE Axis and RAGE Genetics in Chronic Obstructive Pulmonary Disease.
    Sharma A; Kaur S; Sarkar M; Sarin BC; Changotra H
    Clin Rev Allergy Immunol; 2021 Apr; 60(2):244-258. PubMed ID: 33170477
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Advanced Glycation End Products (AGEs), Glutathione and Breast Cancer: Factors, Mechanism and Therapeutic Interventions.
    Sharma AK; Sharma VR; Gupta GK; Ashraf GM; Kamal MA
    Curr Drug Metab; 2019; 20(1):65-71. PubMed ID: 30207227
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of Receptor for Advanced Glycation End Products in Regulating Lung Fluid Balance in Lipopolysaccharide-induced Acute Lung Injury and Infection-Related Acute Respiratory Distress Syndrome.
    Wang H; Wang T; Yuan Z; Cao Y; Zhou Y; He J; Shen Y; Zeng N; Dai L; Wen F; Chen L
    Shock; 2018 Oct; 50(4):472-482. PubMed ID: 29040215
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Advanced glycation end products and their receptor in age-related, non-communicable chronic inflammatory diseases; Overview of clinical evidence and potential contributions to disease.
    Reynaert NL; Gopal P; Rutten EPA; Wouters EFM; Schalkwijk CG
    Int J Biochem Cell Biol; 2016 Dec; 81(Pt B):403-418. PubMed ID: 27373680
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potential forensic application of receptor for advanced glycation end products (RAGE) and aquaporin 5 (AQP5) as novel biomarkers for diagnosis of drowning.
    Lee SY; Ha EJ; Cho HW; Kim HR; Lee D; Eom YB
    J Forensic Leg Med; 2019 Feb; 62():56-62. PubMed ID: 30677703
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma miR-185 is decreased in patients with esophageal squamous cell carcinoma and might suppress tumor migration and invasion by targeting RAGE.
    Jing R; Chen W; Wang H; Ju S; Cong H; Sun B; Jin Q; Chu S; Xu L; Cui M
    Am J Physiol Gastrointest Liver Physiol; 2015 Nov; 309(9):G719-29. PubMed ID: 26316588
    [TBL] [Abstract][Full Text] [Related]  

  • 13. All the "RAGE" in lung disease: The receptor for advanced glycation endproducts (RAGE) is a major mediator of pulmonary inflammatory responses.
    Oczypok EA; Perkins TN; Oury TD
    Paediatr Respir Rev; 2017 Jun; 23():40-49. PubMed ID: 28416135
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The receptor for advanced glycation endproducts (RAGE) decreases survival of tumor-bearing mice by enhancing the generation of lung metastasis-associated myeloid-derived suppressor cells.
    Wuren T; Huecksteadt T; Beck E; Warren K; Hoidal J; Ostrand-Rosenberg S; Sanders K
    Cell Immunol; 2021 Jul; 365():104379. PubMed ID: 34038758
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lung adenocarcinoma expressing receptor for advanced glycation end-products with primary systemic AL amyloidosis: a case report and literature review.
    Okamoto S; Togo S; Nagata I; Shimizu K; Koinuma Y; Namba Y; Ito J; Uekusa T; Takahashi K
    BMC Cancer; 2017 Jan; 17(1):22. PubMed ID: 28056871
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Systematic Analysis of the Prognostic Significance and Roles of the Integrin Alpha Family in Non-Small Cell Lung Cancers.
    Huang Y; Guo DM; Bu S; Xu W; Cai QC; Xu J; Jiang YQ; Teng F
    Adv Ther; 2023 May; 40(5):2186-2204. PubMed ID: 36892810
    [TBL] [Abstract][Full Text] [Related]  

  • 17. RAGE and Its Ligands: Molecular Interplay Between Glycation, Inflammation, and Hallmarks of Cancer-a Review.
    Palanissami G; Paul SFD
    Horm Cancer; 2018 Oct; 9(5):295-325. PubMed ID: 29987748
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term endurance running activity causes pulmonary changes depending on the receptor for advanced glycation end-products.
    Al-Robaiy S; Kindermann A; Wodischeck S; Simm A; Treede H; Bartling B
    Pflugers Arch; 2018 Oct; 470(10):1543-1553. PubMed ID: 29982950
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The shedding-derived soluble receptor for advanced glycation endproducts sustains inflammation during acute Pseudomonas aeruginosa lung infection.
    Antonelli A; Di Maggio S; Rejman J; Sanvito F; Rossi A; Catucci A; Gorzanelli A; Bragonzi A; Bianchi ME; Raucci A
    Biochim Biophys Acta Gen Subj; 2017 Feb; 1861(2):354-364. PubMed ID: 27913191
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Receptor for advanced glycation end products contributes to postnatal pulmonary development and adult lung maintenance program in mice.
    Fineschi S; De Cunto G; Facchinetti F; Civelli M; Imbimbo BP; Carnini C; Villetti G; Lunghi B; Stochino S; Gibbons DL; Hayday A; Lungarella G; Cavarra E
    Am J Respir Cell Mol Biol; 2013 Feb; 48(2):164-71. PubMed ID: 23144333
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.